Skip to content

Polaryx Therapeutics, Inc. PLYX Balance Sheet Statement

Q1 '26Q4 '25Q1 '25Q4 '24Q3 '24
$3.08M+1,132%$5.14M+11.3%$250K$4.62M
$3.5M$5.17M+3.4%$5M
$3.5M$5.17M+3.4%$5M
$850K+5,100%$470K+553%-$17K+83.0%$72K-$100.25K
$1.01M$605K+109%$289K
$1.01M$605K+109%$289K
$560M0.0%$560M
-$102.18M-$99.64M-9.9%-$90.65M
$2.49M-41.5%$4.57M-3.1%$4.25M$4.71M+269%
$3.5M$5.17M+3.4%$5M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Polaryx Therapeutics, Inc. 's total assets?
Polaryx Therapeutics, Inc. (PLYX) holds $3.5M in total assets.
How much cash does Polaryx Therapeutics, Inc. have?
Polaryx Therapeutics, Inc. holds $3.1M in cash and equivalents.
Can Polaryx Therapeutics, Inc. cover its short-term obligations?
Its current ratio is 3.45 — current assets exceed current liabilities.
Where does Polaryx Therapeutics, Inc. 's balance sheet data come from?
Every line is extracted from Polaryx Therapeutics, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.